Liposomal Amphotericin B Fosters the Corticosteroids’ Anti-inflammatory Effect on Murine Allergic Bronchopulmonary Aspergillosis Model Airways

  • Chizu Fukushima
  • Hiroto Matsuse
  • Yasushi ObaseEmail author
  • Susumu Fukahori
  • Tomoko Tsuchida
  • Tetsuya Kawano
  • Shigeru Kohno
  • Hiroshi Mukae
Original Article


Fungus is an antigen for bronchial asthma causing allergic bronchopulmonary mycosis (ABPM). As a therapy other than corticosteroids, itraconazole (ITCZ) is known to suppress the allergic inflammation induced by Aspergillus fumigatus (Af). However, the efficacy of liposomal amphotericin B (LAMB) with/without corticosteroid on ABPM is unknown. Mice sensitized to Dermatophagoides farinae (Df) allergen were intranasally infected with Af (DfAf group). After the infection, corticosteroid (dexamethasone (Dex)) was administered for 5 days (DfAf/Dex group). The effects of ITCZ or LAMB with/without Dex were also evaluated. Pathologically, Dex and LAMB combination treatment decreased the allergic inflammation evidently. The bronchoalveolar lavage fluid (BALF) concentrations of IL-5, IL-13, and MIP-2 were significantly elevated in DfAf mice compared with control mice (p < 0.05, each). In DfAf mice, ITCZ and LAMB significantly decreased the elevation of MIP-2 (p < 0.05 vs the DfAf group). The addition of both Dex and LAMB suppressed the MIP-2 elevation in DfAf mice (p < 0.05 vs the Df/Af/Dex/LAMB group), but the addition of Dex and ITCZ did not (DfAf/Dex/ITCZ group). None of Dex, ITCZ, or LAMB decreased pulmonary IL-13 concentration. It was suggested that combination of antifungal drugs and corticosteroid enhanced the suppressing effect of airway inflammations. This finding will give a hope for the treatment of severe fungus-related asthma.

Key Words

allergic bronchopulmonary aspergillosis (ABPA) murine asthma model Dermatophagoides farinae (Df) itraconazole (ITCZ) liposomal amphotericin B (LAMB) 


Compliance with Ethical Standards

The procedures were reviewed and approved by the Nagasaki University School of Medicine Committee on Animal Research (No. 0307170304).


  1. 1.
    Maturu, V.N., and R. Agarwal. 2015. Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis. Clinical and Experimental Allergy 45: 1765–1778.CrossRefGoogle Scholar
  2. 2.
    Agarwal, R., A.N. Aggarwal, D. Gupta, and S.K. Jindal. 2009. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. The International Journal of Tuberculosis and Lung Disease 13: 936–944.Google Scholar
  3. 3.
    Greenberger, P.A. 2002. Allergic bronchopulmonary aspergillosis. The Journal of Allergy and Clinical Immunology 110: 685–692.CrossRefGoogle Scholar
  4. 4.
    Tillie-Leblond, I., and A.B. Tonnel. 2005. Allergic bronchopulmonary aspergillosis. Allergy 60: 1004–1013.CrossRefGoogle Scholar
  5. 5.
    Gibson, P.G., P.A. Wark, J.L. Simpson, C. Meldrum, S. Meldrum, N. Saltos, and M. Boyle. 2003. Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis. The European Respiratory Journal 21: 582–588.CrossRefGoogle Scholar
  6. 6.
    Kawano, T., H. Matsuse, K. Iida, Y. Kondo, I. Machida, S. Saeki, S. Tomari, Y. Miyazaki, and S. Kohno. 2003. Two cases of allergic bronchopulmonary mycosis caused by Schizophyllum commune in young asthmatic patients. Nihon Kokyūki Gakkai Zasshi 41: 233–236.Google Scholar
  7. 7.
    Muscat, I., S. Oxborrow, and J. Siddorn. 1988. Allergic bronchopulmonary mycosis. Lancet. 1 (8598): 1341.CrossRefGoogle Scholar
  8. 8.
    Greenberger, P.A., and R. Patterson. 1988. Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. The Journal of Allergy and Clinical Immunology 81: 646–650.CrossRefGoogle Scholar
  9. 9.
    McCarthy, D.S., and J. Pepys. 1971. Allergic broncho-pulmonary aspergillosis. Clinical immunology. 2. Skin, nasal and bronchial tests. Clinical Allergy 1: 415–432.CrossRefGoogle Scholar
  10. 10.
    Breslin, A.B., and C.R. Jenkins. 1984. Experience with allergic bronchopulmonary aspergillosis: some unusual features. Clinical Allergy 14: 21–28.CrossRefGoogle Scholar
  11. 11.
    Golbert, T.M., and R. Patterson. 1970. Pulmonary allergic aspergillosis. Annals of Internal Medicine 72: 395–403.CrossRefGoogle Scholar
  12. 12.
    Stevens, D.A., H.J. Schwartz, J.Y. Lee, B.L. Moskovitz, D.C. Jerome, A. Catanzaro, D.M. Bamberger, A.J. Weinmann, C.U. Tuazon, M.A. Judson, T.A. Platts-Mills, and A.C. DeGraff Jr. 2000. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. The New England Journal of Medicine 342: 756–762.CrossRefGoogle Scholar
  13. 13.
    Wark, P.A., M.J. Hensley, N. Saltos, M.J. Boyle, R.C. Toneguzzi, G.D. Epid, J.L. Simpson, P. McElduff, and P.G. Gibson. 2003. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. The Journal of Allergy and Clinical Immunology 111: 952–957.CrossRefGoogle Scholar
  14. 14.
    Wark, P.A., P.G. Gibson, and A.J. Wilson. 2004. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database of Systematic Reviews (3): CD001108.Google Scholar
  15. 15.
    Pasqualotto, A.C., G. Powell, R. Niven, and D.W. Denning. 2009. The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis. Respirology 14: 1121–1127.CrossRefGoogle Scholar
  16. 16.
    Salez, F., A. Brichet, S. Desurmont, J.M. Grosbois, B. Wallaert, and A.B. Tonnel. 1999. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest 116: 1665–1668.CrossRefGoogle Scholar
  17. 17.
    Fukushima, C., H. Matsuse, S. Fukahori, T. Tsuchida, T. Kawano, H. Senjyu, and S. Kohno. 2010. Aspergillus fumigatus synergistically enhances mite-induced allergic airway inflammation. Medical Science Monitor 16: BR197–BR202.Google Scholar
  18. 18.
    Matsuse, H., C. Fukushima, S. Fukahori, T. Tsuchida, T. Kawano, T. Nishino, and S. Kohno. 2013. Differential effects of dexamethasone and itraconazole on Aspergillus fumigatus-exacerbated allergic airway inflammation in a murine model of mite-sensitized asthma. Respiration. 85: 429–435.CrossRefGoogle Scholar
  19. 19.
    Parmar, J.S., T. Howell, J. Kelly, and D. Bilton. 2002. Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax 57: 749–750.CrossRefGoogle Scholar
  20. 20.
    Skov, M., K.M. Main, I.B. Sillesen, J. Müller, C. Koch, and S. Lanng. 2002. Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide. The European Respiratory Journal 20: 127–133.CrossRefGoogle Scholar
  21. 21.
    Patterson, T.F., G.R. Thompson 3rd, D.W. Denning, J.A. Fishman, S. Hadley, R. Herbrecht, D.P. Kontoyiannis, K.A. Marr, V.A. Morrison, M.H. Nguyen, B.H. Segal, W.J. Steinbach, D.A. Stevens, T.J. Walsh, J.R. Wingard, J.A. Young, and J.E. Bennett. 2016. Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the Infectious Diseases Society of America. Clinical Infectious Diseases 63: e1–e60.CrossRefGoogle Scholar
  22. 22.
    Agarwal, R., S. Dhooria, I. Singh Sehgal, A.N. Aggarwal, M. Garg, B. Saikia, D. Behera, and A. Chakrabarti. 2018. A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Chest 153: 656–664.CrossRefGoogle Scholar
  23. 23.
    Ram, B., A.N. Aggarwal, S. Dhooria, I.S. Sehgal, M. Garg, D. Behera, A. Chakrabarti, and R. Agarwal. 2016. A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis. The Journal of Asthma 53: 517–524.CrossRefGoogle Scholar
  24. 24.
    Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, Heussel CP, Lortholary O, Rieger C, Boehme A, Aoun M, Horst HA, Thiebaut A, Ruhnke M, Reichert D, Vianelli N, Krause SW, Olavarria E, Herbrecht R; AmBiLoad Trial Study Group. 2007. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clinical Infectious Diseases 44: 1289–1297.Google Scholar
  25. 25.
    Godet, C., J.C. Meurice, F. Roblot, C. Kauffmann-Lacroix, M. Verdaguer, J.P. Frat, and J. Cadranel. 2012. Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA. The European Respiratory Journal 39: 1261–1263.CrossRefGoogle Scholar
  26. 26.
    Purcell, I.F., and P.A. Corris. 1995. Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema. Thorax 50: 1321–1323.CrossRefGoogle Scholar
  27. 27.
    Kawano, T., H. Matsuse, Y. Kondo, I. Machida, S. Saeki, S. Tomari, K. Mitsuta, Y. Obase, C. Fukushima, T. Shimoda, and S. Kohno. 2003. Cysteinyl leukotrienes induce nuclear factor kappa b activation and RANTES production in a murine model of asthma. The Journal of Allergy and Clinical Immunology 112: 369–374.CrossRefGoogle Scholar
  28. 28.
    Pelikan, Z. 2011. Delayed asthmatic response to bronchial challenge with allergen-mediators, eicosanoids, eosinophil and neutrophil constituents in the blood and urine. Respiration 82: 225–236.CrossRefGoogle Scholar
  29. 29.
    Gibson, P.G., J.L. Simpson, and N. Saltos. 2001. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 119: 1329–1336.CrossRefGoogle Scholar
  30. 30.
    Fairs, A., J. Agbetile, B. Hargadon, M. Bourne, W.R. Monteiro, C.E. Brightling, P. Bradding, R.H. Green, K. Mutalithas, D. Desai, I.D. Pavord, A.J. Wardlaw, and C.H. Pashley. 2010. IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. American Journal of Respiratory and Critical Care Medicine 182: 1362–1368.CrossRefGoogle Scholar
  31. 31.
    Denning, D.W., B.R. O’Driscoll, C.M. Hogaboam, P. Bowyer, and R.M. Niven. 2006. The link between fungi and severe asthma: a summary of the evidence. The European Respiratory Journal 27: 615–626.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Respiratory MedicineNagasaki University Graduate School of Biomedical SciencesNagasakiJapan
  2. 2.Clinical Research CenterNagasaki University HospitalNagasakiJapan
  3. 3.Division of Respiratory Medicine, Department of Internal MedicineToho University Ohashi Medical CenterTokyoJapan

Personalised recommendations